Pfizer Says Its Covid Pill is Highly Effective
By Radiant Health EditorsPublished: November 6, 2021
Pfizer has an antiviral pill for the treatment of Covid-19, and the preliminary results from the trial look promising. The experimental drug decreased deaths and hospitalizations by 90% in high-risk unvaccinated adults. A group of medical experts halted the study because the results were so impressive when compared to the control group. The company will soon ask the FDA to authorize its use, and once it gets approval, it should only be weeks until the pill is made available for doctors to prescribe. Merck’s pill may receive FDA approval first.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- How To Reduce Screen Time On Phone: 5 Helpful Strategies To Help You Stay Connected With The Real World - October 30, 2024
- 11 Wellness Gift Ideas: Perfect Presents for Her that Nurture Body, Mind, and Soul - October 13, 2024
- 11 Best Indoor Air Purifying Plants: Nature’s Air Filters for Your Home - September 27, 2024
- 11 Best Health and Wellness Books to Read in 2024 - July 4, 2024
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022
- FDA Bans Juul’s E-Cigarettes and Cartridges - June 27, 2022
- Polio Virus Found in London Sewage - June 27, 2022